Debt-to-equity of Hoth Therapeutics, Inc. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Hoth Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • Hoth Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 8%, a 3.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Hoth Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 8% 0% +3.7% 30 Sep 2025
Q2 2025 8% -1% -16% 30 Jun 2025
Q1 2025 9% -4% -29% 31 Mar 2025
Q4 2024 9% -4% -31% 31 Dec 2024
Q3 2024 8% -8% -51% 30 Sep 2024
Q2 2024 9% -8% -45% 30 Jun 2024
Q1 2024 12% -2% -15% 31 Mar 2024
Q4 2023 13% -2% -11% 31 Dec 2023
Q3 2023 17% +5% +39% 30 Sep 2023
Q2 2023 17% +5% +42% 30 Jun 2023
Q1 2023 14% +3% +25% 31 Mar 2023
Q4 2022 15% +6% +63% 31 Dec 2022
Q3 2022 12% +3% +31% 30 Sep 2022
Q2 2022 12% +4% +51% 30 Jun 2022
Q1 2022 11% +4% +50% 31 Mar 2022
Q4 2021 9% -1% -13% 31 Dec 2021
Q3 2021 9% -2% -17% 30 Sep 2021
Q2 2021 8% -1% -8.4% 30 Jun 2021
Q1 2021 8% 0% -2.4% 31 Mar 2021
Q4 2020 11% +6% +116% 31 Dec 2020
Q3 2020 11% +6% +119% 30 Sep 2020
Q2 2020 9% 30 Jun 2020
Q1 2020 8% 31 Mar 2020
Q4 2019 5% 31 Dec 2019
Q3 2019 5% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.